Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
jianpi jiedu
- Development stage
- Unknown
- Lead developer
- Shuguang Hospital
- Administration
- Oral
01
Overview
Jianpi Jiedu (JPJD) is a Traditional Chinese Medicine (TCM) herbal formula developed by Shuguang Hospital, affiliated with the Shanghai University of Traditional Chinese Medicine. It is primarily utilized as an adjuvant therapy for patients with colorectal cancer (CRC) to prevent post-operative recurrence and metastasis. The formula is designed according to TCM principles to strengthen the spleen (Jianpi) and clear toxins (Jiedu). Clinical and preclinical studies suggest that JPJD can enhance the efficacy of standard chemotherapy (such as 5-fluorouracil-based regimens), reduce treatment-related toxicity, and inhibit tumor progression by modulating the immune microenvironment, regulating gut microbiota, and suppressing signaling pathways involved in the epithelial-mesenchymal transition (EMT).
- Brand names
- Strengthening Spleen and Relieving Toxin Decoction
- Other names
- Jianpi Jiedu RecipeJianpi Jiedu DecoctionJianpi Jiedu FormulaJianpi Jiedu Tang
02
Targets
HIF1A (Hypoxia-inducible factor 1-alpha)MAPK3 (Mitogen-activated protein kinase 1)RAC1 (Rac family small GTPase 1)RHOA (Ras homolog gene family member A)VEGFA (Vascular endothelial growth factor A)mTOR (Mammalian target of rapamycin kinase)CTNNB1 (Beta-catenin)NF-κB
Beyond the preview
Go deeper on jianpi jiedu.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on jianpi jiedu.